| Bioactivity | Cbl-b-IN-9 (Compound 300) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.6 nM and 4.7 nM, respectively[1]. |
| Target | IC50: 4.7 nM (c-Cbl), 5.6 nM (Cbl-b) |
| Name | Cbl-b-IN-9 |
| CAS | 2815223-41-5 |
| Formula | C30H33F3N6O2 |
| Molar Mass | 566.62 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jun Liang, et al. Lactams as cbl-b inhibitors. Patent WO2022169997A1. |
Cbl-b-IN-9
CAS: 2815223-41-5 F: C30H33F3N6O2 W: 566.62
Cbl-b-IN-9 (Compound 300) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.6 nM and 4.7 nM,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.